title: Rapid rise of serum testosterone following discontinuation of long term treatment of prostate carcinoma with an LHRH-agonist.
authors.affiliation: Department of Medicine, North Shore University Hospital, Manhasset, N.Y.
authors.forename: W
authors.initials: W
authors.lastname: Kreis
authors.forename: D R
authors.initials: DR
authors.lastname: Budman
authors.forename: P
authors.initials: P
authors.lastname: Delli Bovi
authors.forename: V
authors.initials: V
authors.lastname: Vinciguerra
mesh_terms: D002064:Buserelin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D017273:Goserelin; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000097:blood / Q000188:drug therapy*; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000097:blood*; D013739:Testosterone / Q000097:blood*
chemical_list: D017273:Goserelin; D013739:Testosterone; D002064:Buserelin